3-(12,14-Dioxo-10,13,16-triazahexacyclo[14.6.1.02,10.04,9.011,15.019,23]tricosa-1(22),2,4,6,8,11(15),17,19(23),20-nonaen-13-yl)propyl carbamimidothioate

InChIKey	`RUTCIZOQGCWURK-UHFFFAOYSA-N`
Compound Name	3-(12,14-Dioxo-10,13,16-triazahexacyclo[14.6.1.02,10.04,9.011,15.019,23]tricosa-1(22),2,4,6,8,11(15),17,19(23),20-nonaen-13-yl)propyl carbamimidothioate
Canonical SMILES	`N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	6
Pfam Stratification	Cross-Family
Avg pChEMBL	N/A
Source	TTD_MultiTarget

2D Structure

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P04626	ERBB2	Homo sapiens	Human	PF00757 PF14843 PF07714 PF01030 PF21314	Clinical	TTD_MultiTarget	TTD_MultiTarget
P06729	CD2	Homo sapiens	Human	PF05790 PF07686	Clinical	TTD_MultiTarget	TTD_MultiTarget
P08581	MET	Homo sapiens	Human	PF07714 PF01437 PF01403 PF01833	Clinical	TTD_MultiTarget	TTD_MultiTarget
P11802	CDK4	Homo sapiens	Human	PF00069	Clinical	TTD_MultiTarget	TTD_MultiTarget
P24941	CDK2	Homo sapiens	Human	PF00069	Clinical	TTD_MultiTarget	TTD_MultiTarget
P31749	AKT1	Homo sapiens	Human	PF00169 PF00069 PF00433	Clinical	TTD_MultiTarget	TTD_MultiTarget